Identifying druggable targets for differentiation therapy in glioblastoma

Vedi l’offerta su Go Lavoro: golavoro.it/annuncio-lavoro/8p8iwl

Organisation/Company Università di Trento Research Field Biological sciences Researcher Profile Recognised Researcher (R2) Leading Researcher (R4) First Stage Researcher (R1) Established Researcher (R3) Application Deadline 9 Nov 2026 - 12:00 (UTC) Country Italy Type of Contract To be defined Job Status Not Applicable Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No

Offer Description

Glioblastoma (GBM) is the most common and aggressive central nervous system malignancy in adults. This research project aims to identify novel druggable molecular targets to advance differentiation therapy strategies for glioblastoma (GBM).



By inducing terminal differentiation of glioma stem cells (GSCs) and converting stem-like cells into non-stem states sensitive to conventional treatments, this project aims to reduce tumor intrinsic dynamic plasticity and achieve effective GBM eradication. [...]

- AFRICA
- EUROPE
- OCEANIA
- NORTH AMERICA
- SOUTH AMERICA
- ASIA
- OTHER
- E.U.
- CHINA (MAINLAND)
- CHINA (HONG KONG)

Eligibility of fellows: country/ies of residence:

- AFRICA
- EUROPE
- OCEANIA
- NORTH AMERICA
- SOUTH AMERICA
- ASIA
- OTHER
- E.U.
- CHINA (MAINLAND)
- CHINA (HONG KONG)

Vedi l’offerta su Go Lavoro: golavoro.it/annuncio-lavoro/8p8iwl